No data pointing to significant CYP-metabolism or CYP-induction.

(To be edited, initial data ST OCT 04) NMDA (N-methyl-D-aspartate receptor) antagonist used in Alzheimer´s disease. No data (in vitro) pointing to CYP-metabolism or CYP-induction or inhibition.